NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
2.030
-0.120 (-5.58%)
At close: Aug 21, 2026, 4:00 PM EDT
2.310
+0.280 (13.79%)
After-hours: Aug 21, 2026, 7:39 PM EDT
NMTC Revenue
NeuroOne Medical Technologies had revenue of $1.97M in the quarter ending June 30, 2026, with 16.34% growth. This brings the company's revenue in the last twelve months to $12.47M, up 29.49% year-over-year. In the fiscal year ending September 30, 2025, NeuroOne Medical Technologies had annual revenue of $12.10M with 250.35% growth.
Revenue (ttm)
$12.47M
Revenue Growth
+29.49%
P/S Ratio
1.48
Revenue / Employee
$692,706
Employees
18
Market Cap
18.48M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 12.10M | 8.64M | 250.35% |
| Sep 30, 2024 | 3.45M | 45.37K | 1.33% |
| Sep 30, 2023 | 3.41M | 1.29M | 60.73% |
| Sep 30, 2022 | 2.12M | 1.88M | 772.60% |
| Sep 30, 2021 | 242.96K | -1.68M | -87.39% |
| Sep 30, 2020 | 1.93M | - | - |
| Sep 30, 2019 | - | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | 773.00 | -476.00 | -38.11% |
| Dec 31, 2013 | 1.25K | 328.00 | 35.61% |
| Dec 31, 2012 | 921.00 | -4.48K | -82.94% |
| Dec 31, 2011 | 5.40K | 4.23K | 362.55% |
| Dec 31, 2010 | 1.17K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Accuray | 428.57M |
| TELA Bio | 79.91M |
| IRIDEX | 51.57M |
| Cytosorbents | 37.22M |
| Lifeward | 21.82M |
| Pulsenmore | 12.55M |
| Sintx Technologies | 1.33M |
| iTonic Holdings | 523.03K |
NMTC News
- 7 days ago - NeuroOne Medical price target lowered to $5 from $13 at Maxim - TheFly
- 10 days ago - NeuroOne Medical Technologies Earnings Call Transcript: Q3 2026 - Transcripts
- 10 days ago - NeuroOne Medical Technologies Earnings release: Q3 2026 - Filings
- 10 days ago - NeuroOne Medical Technologies Quarterly report: Q3 2026 - Filings
- 2 months ago - NeuroOne Medical Technologies Transcript: Planet MicroCap Las Vegas 2026 - Transcripts
- 2 months ago - NeuroOne Medical Technologies Slides: Corporate presentation - Filings
- 3 months ago - NeuroOne Medical target adjusted to $8 from $1.60 at Ladenburg - TheFly
- 3 months ago - NeuroOne Medical Technologies Earnings Call Transcript: Q2 2026 - Transcripts